1. Evidence-Based Medicine and Healthcare Quality in the Context of Information Failure: The Case of the UK Fertility Sector

   • Minyan Zhu

   Current Opinion Open access 14 August 2021 Pages: 561 - 576

   

2. gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance

   • Susan O’Connell
   • Megan Dale
   • Grace Carolan-Rees

   Review Article Open access 28 July 2021 Pages: 577 - 586

3. Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses

   • Liv Solvår Nymark
   • Alex Miller
   • Anna Vassall

   Systematic Review Open access 04 May 2021 Pages: 587 - 603

   

4. Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review

   • Tamás Zelei
   • Nicholas D. Mendola
   • Jonathan D. Campbell

   Systematic Review Open access 18 May 2021 Pages: 605 - 612

   

5. Hospital Costs of Extracorporeal Membrane Oxygenation in Adults: A Systematic Review

   • Annemieke Oude Lansink-Hartgring
   • Olivier van Minnen
   • the Dutch Extracorporeal Life Support Study Group

   Systematic Review Open access 31 May 2021 Pages: 613 - 623

   

6. Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States

   • Ash Bullement
   • Emma S. Knowles
   • Ron Preblick

   Original Research Article Open access 15 July 2021 Pages: 625 - 633

   

7. A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Chile

   • Manuel Antonio Espinoza
   • Rubén Rojas
   • Carlos Balmaceda

   Original Research Article Open access 05 July 2021 Pages: 635 - 647

   

8. Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan

   • Robin L. Corelli
   • Thanh G. Tu
   • Karen Suchanek Hudmon

   Original Research Article Open access 09 June 2021 Pages: 649 - 653

   

9. Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia

   • Yared Belete Belay
   • Eskinder Eshetu Ali
   • Beate Sander

   Original Research Article Open access 16 June 2021 Pages: 655 - 664

   

10. Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study

    • David J. Mott
    • Iain Leslie
    • Nicolas Scheuer

    Original Research Article Open access 09 May 2021 Pages: 665 - 675

    

11. Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK

    • T. Alexander Russell-Smith
    • James Brockbank
    • Christopher Knight

    Original Research Article Open access 28 June 2021 Pages: 677 - 691

    

12. Cost-Effectiveness of Peer-Educator–Delivered Lifestyle Modification for Type 2 Diabetes Prevention in a Young Healthy Population in Sri Lanka: A Trial-Based Economic Evaluation and Economic Model

    • James Shearer
    • Miral Kalyani
    • Janaka Karalliedde

    Original Research Article Open access 12 July 2021 Pages: 693 - 700

    

13. Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making

    • Jason Gordon
    • Angela Stainthorpe
    • John Borrill

    Original Research Article Open access 02 July 2021 Pages: 701 - 713

    

14. Estimation of Health-Related Utilities for ¹⁷⁷Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities

    • Ioana-Alexandra Soare
    • Oscar Leeuwenkamp
    • Louise Longworth

    Original Research Article Open access 14 July 2021 Pages: 715 - 725

    

15. The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US

    • Satabdi Chatterjee
    • David Walker
    • Rajender R. Aparasu

    Original Research Article Open access 13 July 2021 Pages: 727 - 736

16. Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies

    • Edward C. F. Wilson
    • Alice Wreford
    • Vincent J. Gnanapragasam

    Original Research Article Open access 09 July 2021 Pages: 737 - 753

    

17. Direct and Indirect Costs of Non-surgical Treatment for Acute Tonsillitis in Children in Southeast Nigeria

    • Maduka Donatus Ughasoro
    • James Onuorah Akpeh
    • Obinna Emmanuel Onwujekwe

    Original Research Article Open access 08 April 2021 Pages: 755 - 764

18. Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective

    • Nan Qiao
    • Ralph Insinga
    • Gilberto Lopes

    Original Research Article Open access 22 July 2021 Pages: 765 - 778